Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

4.70
Delayed Data
As of Nov 24
 0.00 / 0.00%
Today’s Change
3.95
Today|||52-Week Range
9.25
-25.75%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues9.0M9.4M3.1M8.8M
 
 
 
 
 
Cost of Goods Sold2.3M122.0K22.0K1.1M
 
 
 
 
 
Depreciation And Amortization172.0K172.0K172.0K178.0K
 
 
 
 
 
 
Operating ExpensesGross Income6.5M9.1M2.9M7.5M
 
 
 
 
 
General Expenses14.7M19.8M18.4M20.9M
 
 
 
 
 
Research And Development12.2M16.8M15.8M17.5M
 
 
 
 
 
Total Operating Expenses17.2M20.1M18.6M22.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.2M-10.7M-15.5M-13.3M
 
 
 
 
 
Extraordinary Credit5.7M0.00521.0K130.0K
 
 
 
 
Extraordinary Charge---1.5M0.000.00
 
 
Interest Expense On Debt2.1M2.1M2.1M2.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.5M-14.2M-16.9M-15.1M
 
 
 
 
 
Net Income-4.5M-14.2M-16.9M-15.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS73.8M75.2M80.4M83.6M
 
 
 
 
 
Shares To Calculate EPS Diluted73.8M75.2M80.4M83.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06-$0.19-$0.21-$0.18
 
 
 
 
 
EPS Diluted-$0.06-$0.19-$0.21-$0.18